Xing Zeng

1.8k total citations
63 papers, 1.1k citations indexed

About

Xing Zeng is a scholar working on Surgery, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Xing Zeng has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 13 papers in Molecular Biology and 12 papers in Reproductive Medicine. Recurrent topics in Xing Zeng's work include Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Immune cells in cancer (6 papers). Xing Zeng is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Immune cells in cancer (6 papers). Xing Zeng collaborates with scholars based in China, Canada and United States. Xing Zeng's co-authors include Run-Yue Huang, Yuanyuan Wang, Xian Zhang, Lucy Gilbert, Anthony Dohan, Reza Forghani, Yoshiko Ueno, Caroline Reinhold, Chunping Liu and Lili Fu and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Xing Zeng

55 papers receiving 1.1k citations

Peers

Countries citing papers authored by Xing Zeng

Since Specialization

Citations

This map shows the geographic impact of Xing Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Zeng more than expected).

Fields of papers citing papers by Xing Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Zeng. The network helps show where Xing Zeng may publish in the future.

Co-authorship network of co-authors of Xing Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Zeng. A scholar is included among the top collaborators of Xing Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Zeng. Xing Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The challenge of managing isolated STIC lesions: A single-center experience 2025 ·Gynecologic Oncology Reports ·(unknown), Basile Tessier‐Cloutier, Lili Fu, (unknown), Xing Zeng, Reitan Ribeiro, (unknown), Lucy Gilbert, (unknown)	0
2	Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer 2025 ·International Journal of Gynecology & Obstetrics ·(unknown), Gabriel Levin, Reitan Ribeiro, (unknown), (unknown), Xing Zeng, John S. Sampalis, Lucy Gilbert	0
3	Comparison of two-dimensional and three-dimensional culture systems and their responses to chemotherapy in cells representing disease progression of high-grade serous ovarian cancer 2024 ·Biochemistry and Biophysics Reports ·(unknown), Alicia A. Goyeneche, (unknown), (unknown), (unknown), Xing Zeng, Basile Tessier‐Cloutier, (unknown), Carlos Telleria	1
4	Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial 2024 ·Trials ·J Belotte, Brunella Felicetti, Amanda Baines, (unknown), Luis Rojas‐Espaillat, (unknown), Diane Provencher, (unknown), Lucía González Cortijo, Xing Zeng	2
5	The Impact of Intrauterine Manipulators on Outcome and Recurrence Patterns of Endometrial Cancer Patients Undergoing Minimally Invasive Surgery 2024 ·Journal of Women s Health ·Ido Laskov, Nadav Michaan, Xing Zeng, Shannon Salvador, Susie Lau, Lucy Gilbert, Walter H. Gotlieb, Roy Kessous	1
6	Homogeneous Polyporus polysaccharide exerts anti-bladder cancer effects via autophagy induction 2024 ·Pharmaceutical Biology ·(unknown), Xiaopeng Huang, Shiqi Li, Yu‐Wen Chen, Xian Zhang, Xing Zeng	4
7	Development and Validation of Multiparametric MRI–based Radiomics Models for Preoperative Risk Stratification of Endometrial Cancer 2022 ·Radiology ·Thierry Lefebvre, Yoshiko Ueno, Anthony Dohan, Avishek Chatterjee, Martin Vallières, (unknown), (unknown), Ives R. Levesque, Xing Zeng, Reza Forghani, Jan Seuntjens, Philippe Soyer, Peter Savadjiev, Caroline Reinhold	66
8	Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment 2021 ·BMC Complementary Medicine and Therapies ·(unknown), (unknown), (unknown), Shiqi Li, (unknown), Meifang Li, Xing Zeng	16
9	Real-world direct healthcare costs of treating recurrent high-grade serous ovarian cancer with cytotoxic chemotherapy 2020 ·Journal of Comparative Effectiveness Research ·Lucy Gilbert, Agnihotram V. Ramanakumar, (unknown), К. Jardon, Xing Zeng, (unknown), Layla Shbat, (unknown), Manuel Borod, Michael Wolfson, Ioanna Papaioannou, Olga Basso, John S. Sampalis	4
10	BRCA testing in women with high-grade serous ovarian cancer: gynecologic oncologist-initiated testing compared with genetics referral 2020 ·International Journal of Gynecological Cancer ·Sabrina Piedimonte, (unknown), William D. Foulkes, Evan Weber, (unknown), (unknown), (unknown), (unknown), Lucy Gilbert, К. Jardon, (unknown), Xing Zeng	20
11	A Distributed Network Intrusion Detection System for Distributed Denial of Service Attacks in Vehicular Ad Hoc Network 2019 ·IEEE Access ·Ying Gao, (unknown), (unknown), (unknown), (unknown), Xing Zeng	88
12	Adjuvant therapy in stage III endometrial cancer confined to the pelvis 2018 ·Gynecologic Oncology ·(unknown), (unknown), Joanne Alfieri, José João Mansure, Lili Fu, Jocelyne Arseneau, Xing Zeng, К. Jardon, Lucy Gilbert, Luís Souhami	11
13	Impact of a Multidimensional Technical Skills Training Session Before Obstetrics and Gynaecology Clerkship Rotation on Performance and Exposure 2018 ·Journal of Obstetrics and Gynaecology Canada ·Cristina Mitric, (unknown), Srinivasan Krishnamurthy, Xing Zeng, (unknown)	1
14	Thymic function in the regulation of T cells, and molecular mechanisms underlying the modulation of cytokines and stress signaling 2017 ·Molecular Medicine Reports ·Fenggen Yan, Xiumei Mo, Junfeng Liu, Siqi Ye, Xing Zeng, Dacan Chen	36
15	BLZF1 expression is of prognostic significance in hepatocellular carcinoma 2015 ·Biochemical and Biophysical Research Communications ·Runyue Huang, Shu‐Guang Su, (unknown), Jia Fu, Xing Zeng	5
16	Glycyrrhizin Suppresses Lung Adenocarcinoma Cell Growth Through Inhibition of Thromboxane Synthase 2014 ·Cellular Physiology and Biochemistry ·Run-Yue Huang, Yong‐Liang Chu, Zebo Jiang, (unknown), Xian Zhang, Xing Zeng	56
17	18β-Glycyrrhetinic Acid Suppresses Cell Proliferation through Inhibiting Thromboxane Synthase in Non-Small Cell Lung Cancer 2014 ·PLoS ONE ·Run-Yue Huang, Yong‐Liang Chu, Qingchun Huang, Xiumin Chen, Zebo Jiang, Xian Zhang, Xing Zeng	37
18	Efficacy of Zhuling polyporus polysaccharide with BCG to inhibit bladder carcinoma 2014 ·Carbohydrate Polymers ·Guowei Zhang, Gui-Fang Qin, Bo Han, (unknown), (unknown), (unknown), Xing Zeng	30
19	Diuretic activity and kidney medulla AQP1, AQP2, AQP3, V2R expression of the aqueous extract of sclerotia of Polyporus umbellatus FRIES in normal rats 2010 ·Journal of Ethnopharmacology ·Guowei Zhang, Xing Zeng, (unknown), Jianan Wei, Haiding Huang	47
20	BUPT at TRECVID 2007: Shot Boundary Detection 2007 ·TRECVID ·Zhicheng Zhao, Xing Zeng, Tao Liu, Anni Cai	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact